# Biodesix, Inc. (BDSX)

- Sector: Healthcare · Industry: Diagnostics and Research
- SEC CIK: 0001439725 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001439725))
- Full page: https://inspectstocks.com/stocks/bdsx
- Data as of: price 2026-09-28; newest filing used 2026-08-05; latest fiscal period ended 2026-06-30

## Grade

**B** on the growth-and-cash rubric, 4 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | passed | $102.9M | $41.6M |
| Revenue growing recently | passed | $102.9M | $88.5M |
| Free cash flow positive | failed | -$20.2M |  |
| Free cash flow growing overall | passed | -$20.2M | -$45.8M |
| Free cash flow growing recently | passed | -$20.2M | -$23.5M |

Business quality (the + / − mark): 2 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | failed | -27.0% |  |
| Healthy profit margin | failed | -27.0% |  |
| Strong operating margin | failed | -20.0% |  |
| Good return on equity | passed | 1,126.2% |  |
| Debt under control | passed | -30.59 |  |
| Turns sales into cash | failed | -19.7% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $102.9M |
| Net income, trailing twelve months | -$27.8M |
| Free cash flow, trailing twelve months | -$20.2M |
| Net margin | -27.0% |
| Operating margin | -20.0% |
| Return on equity | 1,126.2% |
| Debt to equity | -30.59 |
| Diluted EPS, trailing twelve months | -$3.11 |
| Share price | $30.50 |
| Market value | $321.8M |
| Price / sales | 3.1x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/bdsx)
- [Financial statements](https://inspectstocks.com/stocks/bdsx/financials)
- [Competitors](https://inspectstocks.com/stocks/bdsx/peers)
- [Earnings](https://inspectstocks.com/stocks/bdsx/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.